CIBACALCIN Drug Patent Profile
✉ Email this page to a colleague
When do Cibacalcin patents expire, and when can generic versions of Cibacalcin launch?
Cibacalcin is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in CIBACALCIN is calcitonin human. There are fourteen drug master file entries for this compound. Additional details are available on the calcitonin human profile page.
Summary for CIBACALCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 293 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CIBACALCIN at DailyMed |
US Patents and Regulatory Information for CIBACALCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | CIBACALCIN | calcitonin human | INJECTABLE;INJECTION | 018470-001 | Oct 31, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CIBACALCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | CIBACALCIN | calcitonin human | INJECTABLE;INJECTION | 018470-001 | Oct 31, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | CIBACALCIN | calcitonin human | INJECTABLE;INJECTION | 018470-001 | Oct 31, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |